Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel small-molecule inhibitors of RNA polymerase III.

Eukaryotic cell - 1 Apr 2003

Wu Liping, Pan Jing, Thoroddsen Vala, Wysong Deborah R, Blackman Ronald K, Bulawa Christine E, Gould Alexandra E, Ocain Timothy D, Dick Lawrence R, Errada Patrick, Dorr Patrick K, Parkinson Tanya, Wood Tony, Kornitzer Daniel, Weissman Ziva, Willis Ian M, McGovern Karen

Abstract excerpt

A genetic approach utilizing the yeast Saccharomyces cerevisiae was used to identify the target of antifungal compounds. This analysis led to the identification of small molecule inhibitors of RNA polymerase (Pol) III from Saccharomyces cerevisiae. Three lines of evidence show that UK-118005 inhi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Candida albicans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Fungal

Share to Molecular Weight

Share to Protein Subunits

Share to Reaction Time

Share to RNA Polymerase III

Share to RNA, Transfer

Source

Open in PubMed Open full text

Identifiers

PMID: 12684375
DOI: 10.1128/EC.2.2.256-264.2003
PMCID: PMC154847

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12684375-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel small-molecule inhibitors of RNA polymerase III.PMID 12684375Read ↗

RNA-based therapeutics to treat human fungal infectionsSemantic proximity Read ↗

The RNA polymerase II trigger loop functions in substrate selection and is directly targeted by alpha-amanitin.Semantic proximity Read ↗

Mutations in eukaryotic 18S ribosomal RNA affect translational fidelity and resistance to aminoglycoside antibiotics.Semantic proximity Read ↗

Ribosomal P-protein stalk function is targeted by sordarin antifungals.Semantic proximity Read ↗

Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs.Semantic proximity Read ↗

A chemical genomic screen in Saccharomyces cerevisiae reveals a role for diphthamidation of translation elongation factor 2 in inhibition of protein synthesis by sordarin.Semantic proximity Read ↗

Saccharomyces Cerevisiae as a Genetic Model in Anticancer Therapy.Semantic proximity Read ↗

Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiae.Semantic proximity Read ↗

Mutation of the mitochondrial large ribosomal RNA can provide pentamidine resistance to Saccharomyces cerevisiae.Semantic proximity Read ↗

Yeast based small molecule screen for inhibitors of SARS-CoV.Semantic proximity Read ↗

Defects in yeast RNA polymerase II transcription elicit hypersensitivity to G1 arrest induced by Kluyveromyces lactis zymocin.Semantic proximity Read ↗

Small Molecule Microarrays of RNA-Focused Peptoids Help Identify Inhibitors of a Pathogenic Group I IntronSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.